Partner Content Partner Content Combating Antifungal Resistance to be discussed at Superbugs... Antifungal Resistance at Superbugs & Superdrugs 2019
Partner Content Partner Content WHO's Senior Advisor to speak at 21st Annual Superbugs &... WHO to speak at 21st Superbugs & Superdrugs 2019
Partner Content Partner Content Challenges including Funding and Lack of Incentives Hinder A... Explore Challenges in Antibiotic Research
Partner Content Partner Content Registration Officially Opens for the 21st Annual Superbugs ... Registration Opens for 21st Superbugs & Superdrugs 2019
Events Partner Content 21st Annual Superbugs & Superdrugs Conference 21st Annual Superbugs & Superdrugs Conference
Partner Content Partner Content W. J. Wiess and A.S. Lynch invitation to Superbugs & Sup... SMi Group reports: William J.
News Iterum brings first oral penem antibiotic to US market Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
